Independent fund research. Built on SEC filings.

How we research funds

ETF · International Stock · Federated Hermes

Federated Hermes International Leaders ETF (FHIL)

Ticker FHIL · · Holdings as of Jul 31, 2026

Expense ratio
0.48%$48/yr per $10k
Net assets
$3.1Mall share classes
Holdings
86

Bottom line

Is FHIL a good fund? The bottom line

FHIL is an actively managed international stock ETF from Federated Hermes.

It charges 0.48% — about $48 a year on every $10,000 invested, cheaper than 85% of international stock funds we track.

With $3.1 million in net assets and 86 holdings, its largest position is Astrazeneca Plc (3.1%) and the top 10 make up 24.7% of the portfolio.

What stands out

  • Low cost: cheaper than 85% of international stock peers

What to watch

  • Small fund ($3.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What FHIL invests in

The Funds investment objective is to provide long-term capital growth.

The Fund pursues its investment objective of long-term capital growth by investing primarily (that is, more than 50%) in a portfolio of equity securities, including common stock and depositary receipts, issued by foreign (non-U.S.) companies that the Funds investment adviser, Federated Global Investment Management Corp. (the Adviser), has deemed as the best opportunities across its investable universe relative to the companys competitive position or its growth prospects. The Funds portfolio is managed using fundamental company analysis and valuation disciplines. The Adviser expects that, normally, the Fund will be invested primarily in foreign stocks in developed markets. The Fund is permitted, however, to invest in companies from both developed (including the United States) and emerging market countries. The Funds investment strategy focuses on non-U.S. companies whose share price…

From the fund's prospectus (filed Apr 30, 2026).

What FHIL costs

On a $10,000 investment, FHIL's 0.48% expense ratio costs about $48 a year. The median international stock fund charges 0.9%.

See the full FHIL fee table →

FHIL top 10 holdings

#Holding% of fund
1Astrazeneca Plc AZN3.13%
2Asml Holding Nv ASML2.88%
3Federated Hermes Money Market Obligations Trust2.87%
4Hitachi Ltd HTHIY2.50%
5Taiwan Semiconductor Manufacturing Company Ltd TSM2.44%
6Lvmh Moet Hennessy Louis Vuitton Se MC2.33%
7Sony Group Corp SONY2.26%
8Compagnie De Saint-gobain Sa SGO2.13%
9L'air Liquide Sa AI2.12%
10Mitsubishi Ufj Financial Group Inc MUFG2.00%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 24.7% of the fund. See all top 25 holdings and asset mix →

Alternatives to FHIL

More funds like FHIL →

FHIL FAQ

What is the expense ratio of FHIL?
FHIL's expense ratio is 0.48%, which works out to about $48 a year for every $10,000 invested.
Is FHIL a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 85% of international stock peers; small fund ($3.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does FHIL hold?
FHIL's largest holdings are Astrazeneca Plc (3.1%), Asml Holding Nv (2.9%), Federated Hermes Money Market Obligations Trust (2.9%), Hitachi Ltd (2.5%), Taiwan Semiconductor Manufacturing Company Ltd (2.4%). It holds 86 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages FHIL?
FHIL is offered by Federated Hermes through Federated Hermes ETF Trust.